Value through Innovation27 July 2016

Clinical Study Results

  • Volasertib - Leukemia, Myelomonocytic, Chronic
    Clinical Study Number 1230.35
    Study Indication Leukemia, Myelomonocytic, Chronic
    Product Volasertib
    Generic Name Volasertib
    Lab Code BI 6727
    Clinical Phase I
    Study Title

    An open label Phase I trial of intravenous volasertib in combination with subcutaneous azacitidine in Japanese patients with higher-risk myelodysplastic syndrome or chronic myelomonocytic leukemia

    Study Document Trial synopsis 1230.35 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.